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Objectives: Studies have proposed two opposing roles for copper-bound forms of prion protein (PrP) as an 
anti-oxidant supporting the neuronal functions and as a pro-oxidant leading to neurodegenerative process 
involving the generation of reactive oxygen species. The aim of this study is to test the hypothesis in which 
putative copper-binding peptides derived from PrP function as possible catalysts for monoamine-dependent 
conversion of hydrogen peroxide to superoxide in vitro. 
Materials and methods: Four peptides corresponding to the copper (II)-binding motifs in PrP were synthesized 
and used for analysis of peptide-catalyzed generation of superoxide in the presence of Cu (II) and other factors 
naturally present in the neuronal tissues. 
Results: Among the Cu-binding peptides tested, the amino acid sequence corresponding to the Cu-binding site 
in the helical region was shown to be the most active for superoxide generation in the presence of Cu(II), 
hydrogen peroxide and aromatic monoamines, known precursors or intermediates of neurotransmitters. 
Among monoamines tested, three compounds namely phenylethylamine, tyramine and benzylamine were 
shown to be good substrates for superoxide-generating reactions by the Cu-bound helical peptide.  
Conclusions: Possible roles for these reactions in development of prion disease were suggested. 
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1.  Introduction 
Prion protein (PrP) from the brains of animals 
with transmissible spongiform encephalopathies (TSE) 
is present as partially protease-resistant form while 
that in uninfected brains presents as fully sensitive 
form [1]. In general, the former represents the 
infectious scrapie isoform of PrP (PrPSc) and the latter 
represents the intrinsic cellular PrP (PrPC). Such 
deposition of abnormal protein fibrils is a prominent 
pathological feature of many different “protein 
conformational” diseases, including not only “prion” 
dementias but also some important 
neurodegenerative diseases such as Alzheimer’s 
disease, Parkinson’s disease and motor neuron 
disease [2]. In the cases of β-amyloid which 
accumulates in the brain in Alzheimer’s disease and of 
α-synuclein accumulating in Lewy bodies in 
Parkinson’s disease, there are good evidences that the 
toxic mechanism involves the production of reactive 
oxygen species (ROS) such as H2O2 and hydroxyl 
radicals (HO·), supporting the view that one of the 
fundamental molecular mechanisms underlying the 
pathogenesis of cell death in neurodegenerative 
diseases could be the direct production of ROS during 
formation of the abnormal protein aggregates [2,3]. 
As generalized in Fig. 1, PrPs from mammals 
have six to seven putative Cu-binding sites consisted 
of 4 distinct sequences. Opazo et al. [4] have 
propounded the importance of metals in neurobiology 
and proposed two opposing roles for copper-bound 
PrP as an anti-oxidant required for the neuronal 
functions and as a pro-oxidant leading to 
neurodegenerative process. To date, anti-oxidative 
roles of PrPC are well recognized. It has been shown 
that E. coli cells expressing PrP sequence (octapeptide 
repeats region) acquired the resistance to Cu and 
Cu-dependent oxidative damages, indicating that 
PrPC possibly contributes to protection of cells from 
free Cu-catalyzed generation of ROS such as HO· [5]. 
According to Wong et al. [6], Cu-bound PrPC shows a 
superoxide dismutase (SOD)-like activity in vitro, and 
its expression likely contributes to the cellular 
response to oxidative damages to the cells. Sauer et al. 
[7] have shown in tumor spheroids that an increase in 
ROS stimulates the production of PrPC and other ROS 
scavenging enzymes such as Cu, Zn-SOD and catalase, 
while ROS-lowering treatments effectively 
down-regulate the expression of PrPC, implying that 
PrPC expression in tumor spheroids is regulated by 
the internal redox state to meet the requirement to 
protect the cells from ROS. Interestingly, a drastic 
depress in SOD-like activity has been shown in the 
affinity-purified total PrP preparation isolated from 
scrapie-infected mouse brains suggesting that prion 
disease results in denature of PrP thus no longer 
active in ROS removal [6]. 
However, contrary to above reports, there are 
views questioning the proposed SOD-like activity of 
PrPs. Jones et al. [8] have reported that recombinant 
PrP exhibits no detectable dismutase activity above 
baseline levels measured for copper (II) ions.  Int. J. Biol. Sci. 2007, 3  58
It is generally accepted that, like amyloid-β 
peptide, prion induces apoptotic cell death in 
neuronal tissues [9]. A PrP amino acid sequence 
106-126 covering a putative Cu-binding site, likely 
forms the region causing neuronal apoptosis since a 
synthetic Cu-bound peptide corresponding to PrP 
106-126 is highly fibrillogenic and highly toxic to 
neuronal cells as if behaving as a PrPSc mimic [9,10]. 
Figure 1. Copper-binding motifs in PrP protein. (A) Putative copper-binding domains present in PrP protein and variations 
in amino acid sequences required for binding to copper. Histidine residues possibly involved in anchoring of copper are 
marked with asterisks. (B) Four peptide sequences corresponding to copper-binding motifs in PrP. (1) The most 
characterized Cu-binding sequence repeated 4 times in human, mouse and ovine, 6 times in bovine was used. (2) An 
additional Cu binding sequence found in the basic region in human and mouse PrPs immediately after the octarepeats. (3) 
PrPs from mammals and chicken show similar sequences, but human sequence was tested. (4) Well characterized analog for 
PrP helix 2 sequence was used [33]. The PrP helix 2 sequences varied among species but the Cu-anchoring H residue is 
highly conserved in various mammals such as mouse, bovine, ovine, tammar wallaby, brush-tailed possum, and Brazilian 
opossum. 
 
 
 
Through  in vitro studies with electron spin 
resonance spectroscopy, Allsop and his colleagues 
have shown that H2O2 (detected with a spin trap after 
conversion to HO· via Fenton reaction) is produced 
during the early stages of protein aggregation 
associated with neurodegenerative diseases involving 
β-amyloid, α-synuclein and toxic forms of PrP [11-13]. 
Especially Cu-loaded PrP 106-126, the neurotoxic 
region, likely catalyzes the robust generation of H2O2 
[12].  
In addition to the Cu-loaded PrP 
peptide-dependent formation of H2O2, the present 
study reports the production of superoxide anion 
(O2•-), another key member of ROS in biological 
systems, by Cu-binding PrP fragments in the presence 
of certain co-factors. Previously, the author has 
proposed a hypothetical model mechanism in which 
Cu-bound form of PrP catalyzes the generation of 
ROS in the presence of some natural co-factors at 
specific occasions in the neuronal tissues [14]. The 
author has made a speculation that aromatic 
monoamines may form a group of such co-factors 
possibly contributing to the PrP-dependent oxidative 
burst [14] since Cu-bound PrP has high affinity and 
catalytic activity for oxidation of some aromatic 
monoamines such as dopamine which is abundantly 
present in neuronal tissues [15]. The aim of the present 
study is to test the hypothesis in which putative 
Cu-binding peptides derived from PrP function as 
possible catalysts for monoamine-dependent 
conversion of H2O2 to O2•- in vitro. 
2.  Materials and methods 
Peptides 
Four peptides corresponding to each Cu-binding 
sequence in PrP protein were synthesized to examine 
t h e  b e h a v i o r  o f  s u c h  Cu-binding domains in 
chemiluminescence analysis of peptide-mediated 
oxidative burst. The peptides were obtained from the 
custom peptide service department of Sigma Genosis 
Japan (Ishikari, Hokkaido). The amino acid sequences 
of the peptides chemically synthesized and purified 
o n  h i g h  p r e s s u r e  l i q u i d  c h r o m a t o g r a p h y  w e r e  ( 1 )  
PHGGGWGQ (purity, 95.72%), (2) GGGTH (purity, 
98.98%), (3) KTNMKHMA (purity, 98.85%) and (4) 
VNITKQHTVTTTT (purity, 99.02%). 
Chemicals 
2-Methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]py
razin-3-one  (Cypridina luciferin analog, CLA), a 
chemiluminescence reagent specific to O2•-, was 
purchased from Tokyo Kasei Kogyo Co. (Tokyo, 
Japan). Phenylethylamine (PEA), tyramine 
hydrochloride, and tryptamine hydrochloride were 
purchased from Wako Pure Chemical Industries Ltd. 
(Osaka, Japan). Benzylamine, dopamine 
hydrochloride, and serotonin were from Nakalai 
Tesque Inc. (Kyoto, Japan). Other chemicals used in 
this study were of reagent grade purchased from 
Sigma (St. Louis, MO, USA). Int. J. Biol. Sci. 2007, 3  59
Detection of superoxide 
The peptides and other chemicals were dissolved 
in phosphate buffered saline and generation of O2•- 
was monitored by chemiluminescence of CLA with a 
CHEM-GLOW Photometer (American Instrument Co., 
MD., USA) equipped with a pen recorder, and 
expressed as relative luminescence units (rlu) as 
previously described [16]. CLA-chemiluminescence 
specifically indicates the generation of O2•- (and 1O2 
with a lesser extent) but not that of O3, H2O2 or HO• 
[17]. According to our previous study, the signal for 
1O2 can be minimized by avoiding the use of high 
concentration of organic solvents such as ethanol over 
2% (v/v) in the culture media [18]. Thus the induced 
chemiluminescence recorded here reflects the 
generation of O2•- rather than 1O2. 
3.  Results 
Aromatic monoamine-dependent oxidative burst 
catalyzed by the helical Cu-bound peptide 
Since earlier studies suggested the high affinity 
of PrP towards dopamine and related monoamines 
[15], direct interactions between PrP-derived peptides 
and some aromatic monoamines leading to generation 
of O2•- was examined in phosphate buffered saline 
containing 5 µM CLA, by measuring the O2•--specific 
chemiluminescence. However, we observed no 
increase in O2•--dependent chemiluminescence in the 
reaction mixture simply consisted of peptides and 
aromatic monoamines (data not shown). Then, 
addition of other co-factors such as CuSO4 and H2O2 
were examined by analogy to the 
catecholamine-dependent oxidative burst-catalyzing 
enzymes such as copper-amine oxidases, monoamine 
oxidases and monoamine-oxidizing peroxidases. Here, 
generation of O2•- was examined by adding CLA, 
peptide, Cu, H2O2 and aromatic monoamines to 
phosphate buffered saline in this order. In the reaction 
mixture (200 µl) containing helical peptide 
(VNITKQHTVTTTT), Cu2+, H2O2, and 
phenylethylamine (PEA) with an approximate molar 
ratio of  1 : 3 : 3 : 10, a robust increase in the 
O2•--dependent chemiluminescence was observed (Fig. 
2A). The observed burst of O2•- production was a 
biphasic event consisting of the acute spike and the 
gradual increase in O2•-. As discussed below, the 
PEA-induced acute spike can be observed in the 
Cu-H2O2 solution lacking peptides, only the later 
phase with gradual large increase in 
chemiluminescence must be attributed to the helical 
peptide-dependent reactions. Other peptides except 
for GGGTH also showed catalytic activity leading to 
biphasic O2•- production with lesser extents. Here 
again, only the secondary phase of oxidative burst 
must be considered as the consequences of peptide 
chemistry. Among the peptides, the activity of 
VNITKQHTVTTTT peptide sequence was 
outstanding thus is of great interests. 
The cases of tyramine instead of PEA added to 
the reaction mixture containing 5 μM CLA, 0.3 µM 
helical peptide, 0.9 µM CuSO4, and 1 mM H2O2 are 
shown in Fig. 2B. Effects of various aromatic amines 
namely PEA, tyramine, dopamine, serotonin, 
tryptamine, benzylamine, on generation of O2•- in 
peptide-Cu-H2O2 system were compared (Fig. 2B, 
upper inset). Among the aromatic monoamines, only 
three monoamines, PEA, tyramine, and benzylamine 
induced the generation of O2•-, and the structures of 
such active monoamines are shown in Fig. 2C. In 
addition, effects of two salicylates known to stimulate 
the conversion of H2O2 to O2•- by human 
methemoglobin [19,20] and various peroxidases [20], 
were also tested (Fig. 2B, upper inset). However, these 
salicylates were shown to be poor substrates for the 
generation of O2•- in this system. Interestingly, five 
related compounds inactive in induction of O2•- 
namely, serotonin, tryptamine, dopamine, salicylate 
and aspirin were shown to interfere with the 
PEA-induced O2•--generating reaction (Fig. 2B, lower 
inset), opening the ways for chemical and clinical 
modulation or manipulation of the 
monoamine-dependent oxidative burst in the PrP rich 
neuronal tissues. 
As the helical peptide was shown to be most 
active among four Cu-binding peptides derived from 
PrP as the catalyst for PEA-dependent generation of 
O2•-, three other peptides less active towards PEA 
were shown to be also poorly active even towards 
tyramine and benzylamine (data not shown). 
Among, three active monoamines, PEA is the 
most abundant species in neuronal tissues since PEA 
is a key precursor for many of catecholamine 
neurotransmitters. It is likely that reaction involving 
PEA is most likely to occur in the neuronal tissues 
compared to the reactions involving tyramine or 
benzylamine, thus following assays were carried out 
using PEA as a possible substrate.  
Requirement for co-factors 
In the reaction mixtures lacking either of 5 
components namely CLA, helical peptide, Cu, H2O2 
and aromatic monoamines, no drastic increase in the 
second phase of O2•--dependent chemiluminescence 
was observed, suggesting that any component is 
necessarily required for the reaction leading to 
generation and detection of O2•-. Typical results for 
peptide-Cu-H2O2-PEA system are shown (Fig. 3). 
Effects of the concentrations of helical peptide (Fig. 
3A), copper (Fig. 3B), H2O2 (Fig. 3C), and PEA (Fig. 3D) 
on O2•- generation were examined. All components of 
the reaction were shown to act in 
concentration-dependent manners, further confirming 
that each component is necessary for the O2•- 
generating reaction and thus each component can be a 
limiting factor. Since the requirement for H2O2 was 
confirmed, the type of reaction catalyzed by the 
Cu-supplemented PrP helical sequence is rather 
similar to the aromatic monoamine oxidation 
reactions leading to O2•-  generation catalyzed by 
H2O2-requiring plant peroxidases [21, 22] or human 
methemoglobin [19]. 
Here, the Cu-loaded peptide-dependent O2•- 
generation was shown to be fueled by H2O2 added to 
the reaction mixture. Actually, supply of H2O2 at the 
micro-domains on Cu-bound whole PrP is possible 
since Cu-loaded PrP 106-126, the neurotoxic region, is 
known to catalyze the production of H2O2 [12]. 
Despite of weak O2•--generating activity of 
KTNMKHMA corresponding to the neurotoxic 
sequence (Fig. 2A), this region may contribute to the 
oxidative burst by producing H2O2. Int. J. Biol. Sci. 2007, 3  60
Figure 2. Superoxide-generating reactions catalyzed by the Cu-supplied PrP peptide fragments. (A) Typical traces of 
O2
•--dependent chemiluminescence increase catalyzed by four putative Cu-binding PrP fragments are shown. Each reaction 
mixture contained CLA (5 μM), either peptide sequence as indicated (0.3 mM each), CuSO4 (0.9 mM), H2O2 (1 mM) and 
PEA (3 mM). (B) Comparison of the actions of aromatic monoamines. Reaction mixtures contained 5 μM CLA, 0.3 mM 
helical peptide, 0.9 mM CuSO4, 1 mM H2O2, and 3 mM of aromatic monoamies or salicylates. Typical traces for 
tyramine-induced oxidative burst with and without helical peptide are shown. The O2
•--generating activities of related 
compounds were compared in upper inset. Asterisk, O2
•- can be observed in serotonin-Cu solution lacking the peptide 
suggesting that observed chemilumienscence is not reflecting the peptide dependent generation of O2
•-. The lower inset 
shows that five compounds shown to be inactive in oxidative burst induction, in turn inhibits the PEA-dependent O2
•- 
generation. Prior to addition of PEA to the reaction mixture, each inhibitory compound (3 mM) was added. (C) Structures of 
aromatic monoamines active in Cu-loaded PrP helical peptide-dependent production of O2
•-. (1) Phenylethylamine (PEA), (2) 
tyramine, (3) benzylamine. 
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Figure 3. Effects of the concentrations of peptide-, copper-, H2O2-, and PEA on superoxide generation. (A) Effect of the 
helical peptide concentration. (B) Effect of CuSO4 concentration. (C) Effect of H2O2 concentration. (D) Effect of PEA 
concentration. Basically, the reaction mixtures contained constant amounts of CLA (5 μM), the helical peptide sequence (0.3 
mM, exception in A), CuSO4 (0.9 mM, exception in B), H2O2 (1 mM, exception in C) and PEA (3 mM, exception in D). 
 
 
4.  Discussion 
Cu-binding sites on PrP 
Importance of metalloproteins in neurobiology 
has been shown both as oxidant and antioxidant in 
neurodegenerative processes [4]. Cu is an essential 
trace element but its redox reactivity leads to the risk 
of damage to the cells and tissues, especially in 
neurodegenerative diseases such as Menkes’ and 
Wilson’s diseases occurring via disorders of Cu 
metabolism, and Alzheimer’s disease and ‘prion’ 
diseases, the two major conformational diseases, as 
documented [23-25, etc]. The likely roles for Cu in 
induction of critical steps in the apoptotic pathways 
leading to neurodegeneration is outlined in the above 
reviews. 
Recent studies have shown that PrPs can form a 
novel group of Cu-binding proteins [26,27]. Human 
PrP has four Cu-binding sites in the “octarepeats” 
region (PrP 60-91) in which amino acid sequence 
PHGGGWGQ appears four times and each repeat 
possibly binds single Cu2+ at physiological neutral 
and basic range of pH [28]. In general, the most 
relevant copper binding mode would involve 
formation of a 4:1 octarepeat:Cu complex involving 
coordination of one single Cu molecule by the 4 Int. J. Biol. Sci. 2007, 3  62
histidines on the 4 octarepeat segments of a single PrP 
molecule [29]. In chicken, the Cu-binding sites 
analogous to the octarepeats are known as 
hexa-repeats with each repeat consisting of the amino 
acid sequence HNPGYP and here again His residues 
play a key role in anchoring of Cu [30]. Morante et al. 
[31] showed that partial occupancy of Cu on bovine 
PrP is manifested by binding of Cu to PrP in the 
intermolecular or inter-octarepeat orientations while 
total occupancy of Cu is manifested by intra-repeat 
binding of Cu to the octarepeat region. 
In vitro studies have shown that the actual least 
motif in the octarepeats necessarily required for 
binding of Cu consists of 4 amino acids HGGG [28] or 
5 amino acids HGGGW [32]. Although there are 
additional Cu-binding sites on PrP such as amino acid 
regions 92-96 (GGGTH) [27], 124-126 (KHM) [10] and 
180-193 (VNITIKQHTVTTTT) [33], and all studies 
suggested that His residue in each region (or each 
repeat unit) plays a key role in anchoring of Cu (Fig. 1). 
Based on above knowledge, four peptides 
corresponding to Cu-binding domains on PrP, namely 
PHGGGWGQ (repeated in PrP 60-91), GGGTH (PrP 
92-96), KTNMKHMA (PrP 120-127) and 
VNITKQHTVTTTT (helical, PrP 180-193 analog) were 
synthesized in the present study and the helical 
Cu-binding motif was shown to be the most active in 
monoamine-dependent generation of O2•-. Although 
the octarepeat-dependent oxidative burst (second 
phase) was about one forth of the helical 
peptide-dependent one, this amino acid octet is 
repeated 4 times in human PrP and 6 times in bovine 
PrP, its contribution to oxidative burst in whole 
protein can be greater than that observed for the 
single repeat peptide. 
Redox regulations 
The amino-terminal part of PrP (23-98) is rich in 
amino acid residues susceptible to oxidation, such as 
His, Lys, Arg, and Pro, thus PrP is sensitive to 
oxidative changes such as production of ROS and the 
conformational changes in PrP may be readily 
induced by redox changes [15, 34]. In addition to the 
above amino acid residues on PrP, Met residues may 
be good targets for attacks by ROS. Recently, 
H2O2-dependent oxidation of Met residues has been 
reported for recombinant Syrian hamster PrP (29-231) 
[35]. The likely target residues include Met109, Met112, 
Met129 and Met134 and the susceptibility to oxidation of 
each Met residue was shown to be a function of 
accessibility to the solvent. While Cu-catalyzed 
oxidation leads to extensive aggregation of PrP, the 
H2O2-dependent Met oxidation on PrP leads only to a 
modest increase in β-sheet structure. 
According to recently proposed model, there 
may be an intermediate structure of PrP between PrPC 
and PrPSc, to be formed from PrPC in response to 
cellular redox changes thus designated as PrPRDX [36]. 
An  in vitro study demonstrated that PrPRDX of 
recombinant hamster PrP is catalytically active and 
capable of further conversion of PrPC to PrPRDX. At the 
end, PrPRDX accumulates and disulfide bonds are 
formed among each PrPRDX molecule, and lastly 
formation of PrPSc is completed. This attractive model 
successfully explained how pathogenic form of PrP 
could be propagated by the presence of an 
intermediate PrP. 
Note that the PrPRDX originally proposed by Lee 
and Eisenberg [36] was described to be in the 
oligomeric form distinct from the inert SH swapped 
dimeric form. Due to the nature of experimental 
design aimed to produce the redox-activated PrP 
oligomers at once from the SH-opened PrP monomers 
produced by exposing the bulk of PrP to the stepwise 
reduction and oxidation, their model 
(domain-swapping model) lacks the idea on the very 
initial event possibly occurring on a single molecule. 
Here the author wish to mention that PrP-catalyzed 
generation of O2•- (that may attack the SH residues on 
PrP) as a possible redox step(s) that converts the 
monomeric native PrPC to the catalytically active 
monomeric PrPRDX intermediate which in turn acts as 
the seed for further production of PrPRDX from PrPC, 
and to elongate the oligomers. The latest report by 
Shiraishi  et al. [37] supports the view that the Cu 
bound to PrP undergoes catalytic cycling in the 
presence of catecholamines and causes the oxidation 
of protein, possibly involving the ROS-generating 
reactions which is sensitive to copper chelators, 
catalase and also to SOD, implying the involvements 
of H2O2 and O2•-. Possible contribution of 
PrP-catalyzed redox changes such as oxidation of 
catecholamines accompanying productions of H2O2 
and O2•-, in aid of PrPRDX generation is worth of 
further examination. 
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